{"id":"celecoxib-oral-product","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Gastrointestinal disorders (dyspepsia, abdominal pain)"},{"rate":"8-12","effect":"Headache"},{"rate":"5-10","effect":"Hypertension"},{"rate":"1-3","effect":"Cardiovascular events (myocardial infarction, stroke)"},{"rate":"5-8","effect":"Edema"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a selective COX-2 inhibitor, celecoxib preferentially blocks COX-2 while sparing COX-1, which is responsible for protective gastrointestinal and renal functions. This selectivity was designed to provide anti-inflammatory and analgesic effects with a reduced risk of gastrointestinal ulceration compared to non-selective NSAIDs. The drug is used to treat inflammatory conditions and pain by decreasing prostaglandin-mediated inflammation.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:13.099Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Ankylosing spondylitis"},{"name":"Familial adenomatous polyposis (FAP)"}]},"trialDetails":[{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT05343013","phase":"PHASE2","title":"TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-06-06","conditions":"Colorectal Cancer","enrollment":25},{"nctId":"NCT03026140","phase":"PHASE2","title":"Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-03-29","conditions":"Colon Carcinoma","enrollment":353},{"nctId":"NCT04469530","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-09-16","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT06344403","phase":"NA","title":"Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-06-01","conditions":"Herpes Zoster, Local Infiltration, Acute Pain","enrollment":136},{"nctId":"NCT04562610","phase":"PHASE2, PHASE3","title":"Enhanced Recovery After Surgery in Orthopaedic Spine Surgery","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2020-11-18","conditions":"Lumbar Surgery","enrollment":33},{"nctId":"NCT06379425","phase":"PHASE4","title":"Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries","status":"RECRUITING","sponsor":"Northwell Health","startDate":"2024-03-01","conditions":"Pain, Postoperative, Postoperative Pain, Acute","enrollment":70},{"nctId":"NCT03710876","phase":"PHASE3","title":"Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ferring Ventures Limited","startDate":"2019-01-21","conditions":"Malignant Pleural Mesothelioma","enrollment":53},{"nctId":"NCT04041050","phase":"PHASE1","title":"A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2019-11-08","conditions":"Myeloproliferative Neoplasm","enrollment":85},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT06420388","phase":"NA","title":"2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy","status":"RECRUITING","sponsor":"E-DA Hospital","startDate":"2023-05-01","conditions":"Surgery, Pain, Postoperative","enrollment":400},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT06328153","phase":"NA","title":"Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2024-03-15","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT03878524","phase":"PHASE1","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2020-04-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia","enrollment":2},{"nctId":"NCT03728179","phase":"PHASE1","title":"RACIN in Patients With Advanced TIL-negative Solid Tumors","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2019-01-16","conditions":"Solid Tumor, Adult","enrollment":40},{"nctId":"NCT05476679","phase":"PHASE1, PHASE2","title":"Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events","status":"COMPLETED","sponsor":"Raziel Therapeutics Ltd.","startDate":"2022-09-25","conditions":"Submental Fat","enrollment":48},{"nctId":"NCT05994287","phase":"NA","title":"Pain Treatment With Combinations of NSAIDs","status":"COMPLETED","sponsor":"Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty","startDate":"2021-01-01","conditions":"Postoperative Pain, Acute","enrollment":105},{"nctId":"NCT06185543","phase":"PHASE2","title":"A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.","status":"UNKNOWN","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2023-11-19","conditions":"Alzheimer Disease","enrollment":20},{"nctId":"NCT06009900","phase":"NA","title":"Safety and Efficacy of Low-intensity Laser Therapy in the Treatment of Chronic Musculoskeletal Pain","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2023-09-01","conditions":"Pain, Chronic","enrollment":860},{"nctId":"NCT06004947","phase":"PHASE1","title":"A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications","status":"COMPLETED","sponsor":"Amgen","startDate":"2016-01-14","conditions":"Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis","enrollment":32},{"nctId":"NCT03563690","phase":"NA","title":"Different Kinds of Acupuncture Treatment for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Zhejiang Chinese Medical University","startDate":"2018-07-03","conditions":"Knee Osteoarthritis","enrollment":360},{"nctId":"NCT05438303","phase":"PHASE1","title":"Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-06-13","conditions":"Healthy Volunteers","enrollment":59},{"nctId":"NCT04673578","phase":"PHASE2","title":"Adjunctive Celecoxib in Childhood-onset OCD Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2021-06-01","conditions":"Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder","enrollment":80},{"nctId":"NCT02727387","phase":"PHASE2","title":"Protocol for the Treatment of Metastatic Ewing Sarcoma","status":"COMPLETED","sponsor":"Italian Sarcoma Group","startDate":"2009-06-01","conditions":"Ewing's Sarcoma (ES)","enrollment":155},{"nctId":"NCT02748707","phase":"PHASE2","title":"Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2015-08-18","conditions":"Oral Squamous Cell Carcinoma, Carcinoma of Buccal Mucosa, Tongue Cancers","enrollment":64},{"nctId":"NCT05324995","phase":"PHASE2","title":"Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2021-01-01","conditions":"Postoperative Pain, Total Knee Arthroplasty","enrollment":146},{"nctId":"NCT03885596","phase":"PHASE2","title":"Open-Label CA-008 (Vocacapsaicin) in Bunionectomy","status":"COMPLETED","sponsor":"Concentric Analgesics","startDate":"2019-03-25","conditions":"Pain","enrollment":36},{"nctId":"NCT03586934","phase":"PHASE3","title":"Multimodal Analgesia in Shoulder Arthroplasty","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2018-06-01","conditions":"Shoulder Pain, Opioid Use","enrollment":""},{"nctId":"NCT03472469","phase":"PHASE4","title":"MAST Trial: Multi-modal Analgesic Strategies in Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Nonspecific Pain Post Traumatic Injury","enrollment":1561},{"nctId":"NCT04639804","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2020-06-06","conditions":"Healthy","enrollment":60},{"nctId":"NCT04259333","phase":"PHASE4","title":"Celecoxib vs. Acetaminophen/Codeine/Caffeine for Post-operative Analgesia in Rhinoplasty.","status":"UNKNOWN","sponsor":"Blake Raggio","startDate":"2020-03-01","conditions":"Pain, Postoperative, Surgery--Complications, Opioid Analgesic Adverse Reaction","enrollment":60},{"nctId":"NCT02280694","phase":"PHASE2","title":"Low Dose Metronomic Poly-chemotherapy for Metastatic CRC","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2015-01","conditions":"Colorectal Cancer","enrollment":45},{"nctId":"NCT03869203","phase":"NA","title":"Prospective Randomized Controlled Trial of Impact of Enhanced Recovery After Surgery(ERAS) for Outcomes of Total Knee and Hip Arthroplasty","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-05-10","conditions":"Arthroplasty, Replacement, Knee, Hip","enrollment":100},{"nctId":"NCT00022399","phase":"PHASE2","title":"Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2002-04-25","conditions":"Prostate Cancer","enrollment":73},{"nctId":"NCT03822520","phase":"PHASE1","title":"Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2017-06-30","conditions":"Qt Interval, Variation in","enrollment":28},{"nctId":"NCT03549611","phase":"PHASE4","title":"Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain","status":"WITHDRAWN","sponsor":"Kevin J Flynn MD","startDate":"2018-08-01","conditions":"Kidney Calculi, Pain, Postoperative","enrollment":""},{"nctId":"NCT02351934","phase":"PHASE4","title":"Early Diuresis Following Colorectal Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2015-02","conditions":"Colorectal Disorders","enrollment":123},{"nctId":"NCT03391570","phase":"NA","title":"Comparing Postoperative Pain Following COX-2 and Prostanoids Expression","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2017-10-17","conditions":"Female Genital Disease","enrollment":60},{"nctId":"NCT01858571","phase":"PHASE3","title":"Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2013-10","conditions":"Malignant Childhood Neoplasm","enrollment":108},{"nctId":"NCT00223691","phase":"PHASE1","title":"Treatment of Orthostatic Hypotension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2002-03","conditions":"Autonomic Failure, Orthostatic Hypotension","enrollment":389},{"nctId":"NCT02110719","phase":"PHASE4","title":"Decreasing Narcotics in Advanced Pelvic Surgery","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2014-03","conditions":"Narcotic Use, Pain, Constipation","enrollment":138},{"nctId":"NCT02850211","phase":"PHASE4","title":"A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2011-09","conditions":"Rotator Cuff Tear","enrollment":180},{"nctId":"NCT02790203","phase":"NA","title":"Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-06","conditions":"Prevention of Post Operative Ileus","enrollment":100},{"nctId":"NCT00526214","phase":"NA","title":"Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2007-10","conditions":"Intracerebral Hemorrhage","enrollment":44},{"nctId":"NCT00305643","phase":"PHASE3","title":"Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-02","conditions":"Breast Cancer, Colorectal Cancer, Pain","enrollment":11},{"nctId":"NCT00250835","phase":"PHASE2","title":"Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2005-04","conditions":"Rectal Cancer","enrollment":38},{"nctId":"NCT00201773","phase":"PHASE2","title":"Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2003-07","conditions":"Breast Cancer","enrollment":22},{"nctId":"NCT00068770","phase":"PHASE2","title":"Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2003-10","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT00934739","phase":"PHASE2, PHASE3","title":"A Study of High-Risk Oral Cavity Cancer","status":"TERMINATED","sponsor":"National Health Research Institutes, Taiwan","startDate":"2007-06","conditions":"Oral Cavity Cancer","enrollment":150},{"nctId":"NCT00108186","phase":"PHASE1","title":"Celecoxib Treatment for Lung Cancer","status":"WITHDRAWN","sponsor":"US Department of Veterans Affairs","startDate":"2004-10","conditions":"Non-Small-Cell Lung Carcinoma","enrollment":""},{"nctId":"NCT00357500","phase":"PHASE2","title":"Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2005-01","conditions":"Central Nervous System Tumor, Pediatric, Leukemia, Lymphoma","enrollment":101},{"nctId":"NCT01604239","phase":"PHASE4","title":"To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2012-05","conditions":"Osteoarthritis","enrollment":761},{"nctId":"NCT00849966","phase":"PHASE2","title":"Celecoxib for Pediatric Adenotonsillectomy","status":"COMPLETED","sponsor":"Children's Hospital of Eastern Ontario","startDate":"2009-08","conditions":"Tonsillectomy, Adenotonsillectomy, Pain, Postoperative","enrollment":282},{"nctId":"NCT01762891","phase":"NA","title":"CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2003-03","conditions":"Antiphospholipid Antibody Syndrome","enrollment":22},{"nctId":"NCT00981201","phase":"PHASE3","title":"Celecoxib as a Chemopreventive Agent in Current and Former Smokers","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-11","conditions":"Smoking, Prevention","enrollment":219},{"nctId":"NCT00058006","phase":"PHASE2","title":"Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2002-09","conditions":"Head and Neck Cancer, Lung Cancer","enrollment":""},{"nctId":"NCT01503385","phase":"PHASE2","title":"Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences","startDate":"2011-12","conditions":"Lung Cancer","enrollment":100},{"nctId":"NCT01280006","phase":"PHASE1, PHASE2","title":"Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2011-01","conditions":"Obstructive Sleep Apnea, Hypertension, Cardiovascular Diseases","enrollment":12},{"nctId":"NCT01112436","phase":"PHASE4","title":"The Effect of Periarticular Multi-Drug Regimen on Pain After Partial Hip Replacement","status":"UNKNOWN","sponsor":"Chung-Ang University Hosptial, Chung-Ang University College of Medicine","startDate":"2010-05","conditions":"Femoral Neck Fracture","enrollment":258},{"nctId":"NCT01020279","phase":"PHASE1","title":"Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise","status":"COMPLETED","sponsor":"X-pert Med GmbH","startDate":"2009-10","conditions":"Musculoskeletal Pain","enrollment":82},{"nctId":"NCT00904605","phase":"PHASE4","title":"Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee","status":"TERMINATED","sponsor":"Endo Pharmaceuticals","startDate":"2004-06","conditions":"Osteoarthritis of the Knee","enrollment":""},{"nctId":"NCT00904397","phase":"PHASE4","title":"Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain","status":"TERMINATED","sponsor":"Endo Pharmaceuticals","startDate":"2004-07","conditions":"Chronic Low Back Pain","enrollment":98},{"nctId":"NCT00066716","phase":"PHASE2","title":"Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2003-06","conditions":"Esophageal Cancer","enrollment":39},{"nctId":"NCT00729495","phase":"PHASE1","title":"Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib","status":"COMPLETED","sponsor":"POZEN","startDate":"2008-07","conditions":"Healthy Volunteer","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["COX II Inhibitor"],"phase":"phase_3","status":"active","brandName":"Celecoxib Oral Product","genericName":"Celecoxib Oral Product","companyName":"Ferring Ventures Limited","companyId":"ferring-ventures-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}